Answers are grounded in this paper and cite their sources.
Acute severe asthma is an extremely common and serious public health problem in the United States. Current optimum therapy of acute severe asthma includes supplemental oxygenation, nebulized 13-adrenergic receptor agonist therapy, and prompt use of glucocorticosteroids. In view of its low therapeutic index and the availability of more effective, less toxic agents, theophylline is no longer considered a first-line treatment. lpratropium bromide combined with 13agonist may augment bronchodilator responsiveness.
No takes yet. Share an insight, caveat, or question.
Garmon et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: